Siquan Sun

4.6k total citations · 1 hit paper
43 papers, 3.7k citations indexed

About

Siquan Sun is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Siquan Sun has authored 43 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Immunology and 17 papers in Cancer Research. Recurrent topics in Siquan Sun's work include Protease and Inhibitor Mechanisms (14 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (10 papers). Siquan Sun is often cited by papers focused on Protease and Inhibitor Mechanisms (14 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (10 papers). Siquan Sun collaborates with scholars based in United States, United Kingdom and Canada. Siquan Sun's co-authors include Jonathan Sprent, David F. Tough, Xiaohong Zhang, Inkyu Hwang, Lars Karlsson, Robin L. Thurmond, Xiaohong Zhang, James P. Edwards, Hidehiro Kishimoto and Changlu Liu and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Siquan Sun

43 papers receiving 3.6k citations

Hit Papers

Potent and Selective Stimulation of Memory-Phenotype CD8+... 1998 2026 2007 2016 1998 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siquan Sun United States 26 2.5k 947 545 344 249 43 3.7k
Kevin L. Otipoby United States 17 2.7k 1.1× 1.2k 1.3× 483 0.9× 335 1.0× 167 0.7× 29 4.0k
Kurt Bachmaier Canada 26 1.8k 0.7× 1.1k 1.2× 592 1.1× 309 0.9× 255 1.0× 32 3.1k
Maurizio Zanetti United States 36 2.4k 0.9× 1.5k 1.6× 780 1.4× 597 1.7× 308 1.2× 158 4.1k
Karen Toy United States 16 1.1k 0.4× 890 0.9× 752 1.4× 245 0.7× 189 0.8× 18 2.6k
Paula S. Hochman United States 29 2.5k 1.0× 592 0.6× 580 1.1× 250 0.7× 175 0.7× 42 3.4k
Shyr‐Te Ju United States 28 2.0k 0.8× 1.2k 1.3× 323 0.6× 248 0.7× 315 1.3× 75 3.2k
José Van der Heyden Belgium 32 2.1k 0.8× 1.3k 1.3× 872 1.6× 378 1.1× 206 0.8× 61 4.0k
Lars Rogge France 33 2.8k 1.1× 1.2k 1.2× 844 1.5× 366 1.1× 203 0.8× 77 4.5k
Dwain L. Thiele United States 31 1.5k 0.6× 879 0.9× 545 1.0× 800 2.3× 242 1.0× 89 3.6k
Subburaj Ilangumaran Canada 35 1.5k 0.6× 1.6k 1.7× 1.1k 2.0× 475 1.4× 306 1.2× 101 3.6k

Countries citing papers authored by Siquan Sun

Since Specialization
Citations

This map shows the geographic impact of Siquan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siquan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siquan Sun more than expected).

Fields of papers citing papers by Siquan Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siquan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siquan Sun. The network helps show where Siquan Sun may publish in the future.

Co-authorship network of co-authors of Siquan Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Siquan Sun. A scholar is included among the top collaborators of Siquan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siquan Sun. Siquan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Siquan & Changlu Liu. (2015). 7α, 25-dihydroxycholesterol-mediated activation of EBI2 in immune regulation and diseases. Frontiers in Pharmacology. 6. 60–60. 33 indexed citations
2.
Shih, Amy Y., Xia V. Yang, Chester Kuei, et al.. (2012). Identification of Structural Motifs Critical for Epstein-Barr Virus-Induced Molecule 2 Function and Homology Modeling of the Ligand Docking Site. Molecular Pharmacology. 82(6). 1094–1103. 17 indexed citations
3.
Wiener, John J. M., Steven Nguyen, Siquan Sun, et al.. (2012). Pyrazole-based arylalkyne Cathepsin S inhibitors. Part III: Modification of P4 region. Bioorganic & Medicinal Chemistry Letters. 23(4). 1070–1074. 7 indexed citations
4.
Sun, Siquan, et al.. (2011). Cathepsin S inhibitors: 2004 – 2010. Expert Opinion on Therapeutic Patents. 21(3). 311–337. 53 indexed citations
5.
Wiener, John J. M., James P. Edwards, Lars Karlsson, et al.. (2010). Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regions. Bioorganic & Medicinal Chemistry Letters. 20(7). 2375–2378. 11 indexed citations
6.
Bembenek, Scott D., Steven Nguyen, Robin L. Thurmond, et al.. (2010). Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(7). 2379–2382. 13 indexed citations
7.
Wiener, John J. M., Siquan Sun, & Robin L. Thurmond. (2010). Recent Advances in the Design of Cathepsin S Inhibitors. Current Topics in Medicinal Chemistry. 10(7). 717–732. 41 indexed citations
8.
Ameriks, Michael K., Frank U. Axe, Scott D. Bembenek, et al.. (2009). Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements. Bioorganic & Medicinal Chemistry Letters. 19(21). 6131–6134. 18 indexed citations
9.
Ameriks, Michael K., James P. Edwards, Yin Gu, et al.. (2009). Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: Optimization of cellular potency. Bioorganic & Medicinal Chemistry Letters. 19(21). 6135–6139. 11 indexed citations
10.
Wei, Jianmei, Barbara Pio, Siquan Sun, et al.. (2007). Pyrazole-based cathepsin S inhibitors with improved cellular potency. Bioorganic & Medicinal Chemistry Letters. 17(20). 5525–5528. 20 indexed citations
11.
Grice, Cheryl A., Haripada Khatuya, Darin J. Gustin, et al.. (2006). The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(8). 2209–2212. 10 indexed citations
12.
Thurmond, Robin L., Siquan Sun, Clark A. Sehon, et al.. (2004). Identification of a Potent and Selective Noncovalent Cathepsin S Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 308(1). 268–276. 44 indexed citations
13.
Tough, David F., Siquan Sun, Xiaohong Zhang, & Jonathan Sprent. (2000). Stimulation of memory T cells by cytokines. Vaccine. 18(16). 1642–1648. 38 indexed citations
14.
Sprent, Jonathan, Xiaohong Zhang, Siquan Sun, & David F. Tough. (1999). T-Cell turnover in vivo and the role of cytokines. Immunology Letters. 65(1-2). 21–25. 37 indexed citations
15.
Sun, Siquan, Xiaohong Zhang, David F. Tough, & Jonathan Sprent. (1998). Type I Interferon-mediated Stimulation of T Cells by CpG DNA. The Journal of Experimental Medicine. 188(12). 2335–2342. 301 indexed citations
16.
Tough, David F., Siquan Sun, & Jonathan Sprent. (1997). T Cell Stimulation In Vivo by Lipopolysaccharide (LPS). The Journal of Experimental Medicine. 185(12). 2089–2094. 287 indexed citations
17.
Sprent, Jonathan, David F. Tough, & Siquan Sun. (1997). Factors controlling the turnover of T memory cells. Immunological Reviews. 156(1). 79–85. 73 indexed citations
18.
Kelm, Robert J., Siquan Sun, Arthur R. Strauch, & Michael J. Getz. (1996). Repression of Transcriptional Enhancer Factor-1 and Activator Protein-1-dependent Enhancer Activity by Vascular Actin Single-stranded DNA Binding Factor 2. Journal of Biological Chemistry. 271(39). 24278–24285. 31 indexed citations
19.
Cogan, John G., et al.. (1995). Plasticity of Vascular Smooth Muscle α-Actin Gene Transcription. Journal of Biological Chemistry. 270(19). 11310–11321. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026